Greg Wiessner

Senior Research Analyst at TD Cowen

Greg Wiessner is a Senior Research Analyst at TD Cowen specializing in health care and therapeutics, particularly emerging treatments for obesity and metabolic disorders. He is noted for his coverage of companies developing myostatin and activin inhibitors, leveraging proprietary industry research and clinical data to evaluate product pipelines and market opportunities. Wiessner joined TD Cowen after roles at other leading investment firms, building a track record of insightful equity analysis and investor guidance, though specific performance metrics such as TipRanks rankings or returns are not publicly available. He maintains professional credentials that meet industry standards for equity research, including relevant securities licenses.